[PDF][PDF] Mutant EZH2 induces a pre-malignant lymphoma niche by reprogramming the immune response

W Béguelin, M Teater, C Meydan, KB Hoehn, JM Phillip… - Cancer cell, 2020 - cell.com
Cancer cell, 2020cell.com
Follicular lymphomas (FLs) are slow-growing, indolent tumors containing extensive follicular
dendritic cell (FDC) networks and recurrent EZH2 gain-of-function mutations. Paradoxically,
FLs originate from highly proliferative germinal center (GC) B cells with proliferation strictly
dependent on interactions with T follicular helper cells. Herein, we show that EZH2
mutations initiate FL by attenuating GC B cell requirement for T cell help and driving slow
expansion of GC centrocytes that become enmeshed with and dependent on FDCs. By …
Summary
Follicular lymphomas (FLs) are slow-growing, indolent tumors containing extensive follicular dendritic cell (FDC) networks and recurrent EZH2 gain-of-function mutations. Paradoxically, FLs originate from highly proliferative germinal center (GC) B cells with proliferation strictly dependent on interactions with T follicular helper cells. Herein, we show that EZH2 mutations initiate FL by attenuating GC B cell requirement for T cell help and driving slow expansion of GC centrocytes that become enmeshed with and dependent on FDCs. By impairing T cell help, mutant EZH2 prevents induction of proliferative MYC programs. Thus, EZH2 mutation fosters malignant transformation by epigenetically reprograming B cells to form an aberrant immunological niche that reflects characteristic features of human FLs, explaining how indolent tumors arise from GC B cells.
cell.com